Pioneer Launches Venture Group to Fund the Fight Against Rare Pediatric Brain Cancer
/PRNewswire/ -- Pioneer Management Consulting announced today the launch of Pioneer Ventures Group, a new investment arm focused on funding companies...
Stay updated with breaking news from Jeff Liter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Pioneer Management Consulting announced today the launch of Pioneer Ventures Group, a new investment arm focused on funding companies...
Nine candidates for seats on the Steamboat Springs City Council have submitted petitions to have their names on the Nov. 7 ballot. The City Clerk has accepted all nine petitions. District 1 and District 2...
Press release content from Business Wire. The AP news staff was not involved in its creation. New Treatment for Central Nervous System Tumors Enters Phase I Clinical Trials January 12, 2021 GMT MINNEAPOLIS--(BUSINESS WIRE)--Jan 12, 2021-- OX2 Therapeutics, Inc., a privately held Minneapolis company, announces today that they treated their first patient in a phase one human trial of a new treatment developed to combat recurrent high-grade brain tumors. “This is a first-of-its kind immunotherapy that works to treat one of the most aggressive and deadly cancers today,” said Christopher Moert...